title: OK-432 therapy for cervical lymphangioma.
authors.affiliation: Department of Otolaryngology/Head and Neck Surgery, The Hebrew University School of Medicine-Hadassah Medical Center, Jerusalem, Israel.
authors.forename: Jean-Yves
authors.initials: JY
authors.lastname: Sichel
authors.forename: Raphael
authors.initials: R
authors.lastname: Udassin
authors.forename: David
authors.initials: D
authors.lastname: Gozal
authors.forename: Benjamin Z
authors.initials: BZ
authors.lastname: Koplewitz
authors.forename: Itszhak
authors.initials: I
authors.lastname: Dano
authors.forename: Ron
authors.initials: R
authors.lastname: Eliashar
mesh_terms: D000328:Adult; D002648:Child; D002675:Child, Preschool; D005260:Female; D006258:Head and Neck Neoplasms / Q000628:therapy*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D015552:Injections, Intralesional; D018191:Lymphangioma, Cystic / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009333:Neck; D010844:Picibanil / Q000008:administration & dosage*; D012597:Sclerosing Solutions / Q000008:administration & dosage*; D016896:Treatment Outcome
chemical_list: D012597:Sclerosing Solutions; D010844:Picibanil